Skip to main content
Equibles

Verition Fund Management LLC

Position in ARVN — Arvinas, Inc.

CIK 1454027 GREENWICH, CT
Back to ARVN Full portfolio

Position in ARVN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$702,003
-$389,105 QoQ
Shares Held
84,477
-8.2% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARVN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Verition Fund Management LLC holds $156,064,619 across 64 Biotechnology names. ARVN ranks #39 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TECH
BIO-TECHNE Corp
 438,746 $30,997,404
2
159,256 $21,138,048
3 ABVX
Abivax S.A.
 105,791 $14,097,708
4 IDYA
IDEAYA Biosciences, Inc.
 184,054 $6,859,692
5 SNDX
Syndax Pharmaceuticals Inc
 304,939 $6,665,966
6 MRVI
Maravai Lifesciences Holdings, Inc.
 777,738 $4,853,085
7 CYTK
Cytokinetics Inc
 54,889 $4,675,993
8 RPRX
Royalty Pharma plc
 75,000 $4,205,250

All Filings in ARVN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $702,003 84,477
2025-12-31 $1,091,108 91,999
2025-09-30 $681,182 79,951
2025-06-30 $276,978 37,633
2025-03-31 $178,006 25,357
2024-12-31 $1,160,340 60,529
2024-09-30 $951,481 38,631
2024-06-30 $2,431,763 91,351
2024-03-31 $3,118,745 75,551
2023-09-30 $4,240,138 215,893
2023-06-30 $1,767,084 71,196
2023-03-31 $423,842 15,514
2021-06-30 $279,818 3,634
2021-03-31 $2,247,333 33,999
2020-12-31 $6,392,426 75,267
2020-06-30 $2,155,246 64,259